Abstract:Objective The maternal cardiovascular system of women with hypertensive disorders of pregnancy (HDP) can be impaired, with higher rates of left ventricular (LV) remodelling and diastolic dysfunction compared to normotensive pregnancies. The primary objective of this prospective study was to correlate cardiac indices obtained by transthoracic echocardiography (TTE) and circulating angiogenic markers, such as soluble fms‐like tyrosine kinase 1 (sFlt‐1) and placental growth factor (PlGF). Methods 95 women with a pregnancy complicated by HDP and a group of 25 uncomplicated pregnancies at term underwent TTE and blood tests to measure sFlt‐1 and PLGF during the peripartum period (before delivery and within a week of giving birth). Spearman's rank correlation was used to report correlation coefficients between biomarkers and cardiac indices in the HDP population and controls. Results HDP group included 61 (64.2%) preeclamptic patients and, among them, 42 (68.9%) delivered before 37 weeks. 12 HDP out of 95 (12.6%) patients underwent blood samples and TTE after delivery, and, as they showed significantly lower levels of angiogenic markers, they were excluded from the analysis. There was a correlation between sFlt‐1 and LVMI (r=0.246, p=0.026) and E/e' (r=0.272, p=0.014) in HDP (n=83), while in controls sFlt‐1 showed a correlation with RWT (r=0.409, p=0.043), lateral e' (r=‐0.562, p=0.004) and E/e' (r=0.417, p=0.042). PlGF correlated with LVMI (r=‐0.238, p=0.031) in HDP patients and with lateral e' (r=0.466, p=0.022) in controls. sFlt‐1/PlGF ratio correlated with lateral e' (r=‐0.568, p=0.004) and E/e' (r=0.428, p=0.037) in controls and with LVMI (r=0.252, p=0.022) and E/e' (r=0.269, p=0.014) in HDP. Conclusions Although the current data are not able to infer causality, they confirm the intimate relationship between the maternal cardiovascular system and endothelial markers that are used both to diagnose and indicate the severity of HDP. This article is protected by copyright. All rights reserved.

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Relationship Between Expression of Vimentin, Type IV Collagen and Fibronectin in Human Placenta and Pregnancy Induced Hypertension

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Enos and Enos Mrna Expression in Placental Villus and Changes in Plasma Endothelin-1, Nitric Oxide, Calcium, Magnesium, and Relationship of Calcium and Magnesium in Red Blood Cell in Patients with Pregnancy-induced Hypertension

VEGF in the muscular layer of placental blood vessels: immuno-expression in preeclampsia and intrauterine growth restriction and its association with the antioxidant status

Platelet indices and angiogenesis markers in hypertensive disorders of pregnancy

Expression of releted genes associated with cell differentiation in placent from hypertension of pregnancy

[Expression of Fas and FasL in Serum and Placenta of Preeclamptic Pregnancy and Its Significance].

Effects of low-molecular weight heparin on the placental ultrastructure and VEGF expression in cases with fetal growth restriction

Declined placental PLAC1 expression is involved in preeclampsia.

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia

GDF-15 Alleviates Hypoxia-Reoxygenation-Induced Damage to Human Placental Vascular Endothelial Cells by Regulating SIRT1

Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy

Study on Relationship Between the Levels of Interleukin-6 and Immunoglobulin in Maternal and Umbilical Serum of Pregnancy Induced Hypertension

Reduction of Uterine Perfusion Pressure Induced Redistribution of Endothelin Receptor Type-B Between the Intima and Media Contributes to the Pathogenesis of Pregnancy-Induced Hypertension

Hypertensive Disorders of Pregnancy and Fetal Growth Restriction: Clinical Characteristics and Placental Lesions and Possible Preventive Nutritional Targets

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa

Up-regulation of Trim28 in Pregnancy-Induced Hypertension is Involved in the Injury of Human Umbilical Vein Endothelial Cells Through the P38 Signaling Pathway.